ReviewJournal of clinical medicine2022

Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease.

Hengameh Chloè Mirsepasi-LauridsenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.